Extracorporeal membrane oxygenation in critically ill neonatal and pediatric patients with acute respiratory failure: a guide for the clinician

References

• ECLS Registry Report Ann Arbor, MI, USA: Extracorporeal Life Support Organization; 2020.
   Google Scholar
• Mugford M, Elbourne D, Field D. Extracorporeal membrane oxygenation for severe respiratory failure in newborn infants. Cochrane Database Syst Rev. 2008;3:CD001340. DOI:https://doi.org/10.1002/14651858.CD001340.pub2
   Google Scholar
• Rehder KJ, Turner DA, Bonadonna D, et al. Technological advances in extracorporeal membrane oxygenation for respiratory failure. Expert Rev Respir Med. 2012 Aug;6(4):377–384.
   PubMed Web of Science ®Google Scholar
• Garcia JP, Iacono A, Kon ZN, et al. Ambulatory extracorporeal membrane oxygenation: a new approach for bridge-to-lung transplantation. J Thorac Cardiovasc Surg. 2010 Jun;139(6):e137–9.
   PubMed Web of Science ®Google Scholar
• Turner DA, Cheifetz IM, Rehder KJ, et al. Active rehabilitation and physical therapy during extracorporeal membrane oxygenation while awaiting lung transplantation: a practical approach. Crit Care Med. 2011 Dec;39(12):2593–2598.
   PubMed Web of Science ®Google Scholar
• Fuehner T, Kuehn C, Hadem J, et al. Extracorporeal membrane oxygenation in awake patients as bridge to lung transplantation. Am J Respir Crit Care Med. 2012 Jan 20.
   PubMed Web of Science ®Google Scholar
• Olsson KM, Simon A, Strueber M, et al. Extracorporeal membrane oxygenation in nonintubated patients as bridge to lung transplantation. Am J Transplant. 2010 Sep;10(9):2173–2178.
   PubMed Web of Science ®Google Scholar
• Maratta C, Potera RM, van Leeuwen G, et al. Extracorporeal Life Support Organization (ELSO): 2020 pediatric respiratory ELSO guideline. Asaio J. 2020 Sep/Oct;66(9):975–979.
   PubMed Web of Science ®Google Scholar
• Wild KT, Rintoul N, Kattan J, et al. Extracorporeal Life Support Organization (ELSO): guidelines for neonatal respiratory failure. Asaio J. 2020 May;66(5):463–470.
   PubMed Web of Science ®Google Scholar
• Straube T, Cheifetz IM, Jackson KW. Extracorporeal membrane oxygenation for hemodynamic support. Clin Perinatol. 2020 Sep;47(3):671–684.
   PubMed Web of Science ®Google Scholar
• Haile DT, Schears GJ. Optimal time for initiating extracorporeal membrane oxygenation. Semin Cardiothorac Vasc Anesth. 2009 Sep;13(3):146–153.
   PubMedGoogle Scholar
• Nehra D, Goldstein AM, Doody DP, et al. Extracorporeal membrane oxygenation for nonneonatal acute respiratory failure: the Massachusetts General Hospital experience from 1990 to 2008. Arch Surg. 2009 May;144(5):427–432. discussion 432.
   PubMedGoogle Scholar
• Pranikoff T, Hirschl RB, Steimle CN, et al. Mortality is directly related to the duration of mechanical ventilation before the initiation of extracorporeal life support for severe respiratory failure. Crit Care Med. 1997 Jan;25(1):28–32.
   PubMed Web of Science ®Google Scholar
• Domico MB, Ridout DA, Bronicki R, et al. The impact of mechanical ventilation time before initiation of extracorporeal life support on survival in pediatric respiratory failure: a review of the extracorporeal life support registry. Pediatr Crit Care Med. 2012 Jan;13(1):16–21.
   PubMed Web of Science ®Google Scholar
• Zabrocki LA, Brogan TV, Statler KD, et al. Extracorporeal membrane oxygenation for pediatric respiratory failure: survival and predictors of mortality. Crit Care Med. 2011 Feb;39(2):364–370.
   PubMed Web of Science ®Google Scholar
• Mehta NM, Turner D, Walsh B, et al. Factors associated with survival in pediatric extracorporeal membrane oxygenation–a single-center experience. J Pediatr Surg. 2010 Oct;45(10):1995–2003.
   PubMed Web of Science ®Google Scholar
• MacLaren G, Butt W, Best D, et al. Central extracorporeal membrane oxygenation for refractory pediatric septic shock. Pediatr Crit Care Med. 2011 Mar;12(2):133–136.
   PubMed Web of Science ®Google Scholar
• Cheung PY, Etches PC, Weardon M, et al. Use of plasma lactate to predict early mortality and adverse outcome after neonatal extracorporeal membrane oxygenation: a prospective cohort in early childhood. Crit Care Med. 2002 Sep;30(9):2135–2139.
   PubMed Web of Science ®Google Scholar
• Zhao J, Liu J, Feng Z, et al. Clinical outcomes and experience of 20 pediatric patients treated with extracorporeal membrane oxygenation in Fuwai Hospital. ASAIO J. 2008 May-Jun;54(3):302–305.
   PubMed Web of Science ®Google Scholar
• Yuan Y, Gao G, Long C, et al. Retrospective analysis of 99 patients with the application of extracorporeal membrane oxygenation in Fuwai Hospital. ASAIO J. 2009 Sep-Oct;55(5):474–477.
   PubMed Web of Science ®Google Scholar
• ELSO Guidelines for Cardiopulmonary Extracorporeal Life Support Ann Arbor, MI, USA: Extracorporeal Life Support Organization; 2017. Available from: https://www.elso.org/Portals/0/ELSO%20Guidelines%20General%20All%20ECLS%20Version%201_4.pdf
   Google Scholar
• Turner DA, Rehder KJ, Peterson-Carmichael SL, et al. Extracorporeal membrane oxygenation for severe refractory respiratory failure secondary to 2009 H1N1 influenza A. Respir Care. 2011 Jul;56(7):941–946.
   PubMed Web of Science ®Google Scholar
• Friedman ML, Barbaro RP, Bembea MM, et al. Mechanical ventilation in children on venovenous ECMO. Respir Care. 2020 Mar;65(3):271–280.
   PubMed Web of Science ®Google Scholar
• Pediatric acute respiratory distress syndrome: consensus recommendations from the pediatric acute lung injury consensus conference. Pediatr Crit Care Med. 2015 Jun;16(5):428–439.
   PubMed Web of Science ®Google Scholar
• Rimensberger PC, Cheifetz IM. Ventilatory support in children with pediatric acute respiratory distress syndrome: proceedings from the pediatric acute lung injury consensus conference. Pediatr Crit Care Med. 2015 Jun;16(5 Suppl 1):S51–60.
   PubMed Web of Science ®Google Scholar
• Hermon M, Burda G, Male C, et al. Surfactant application during extracorporeal membrane oxygenation improves lung volume and pulmonary mechanics in children with respiratory failure. Crit Care. 2005;9(6):R718–24.
   PubMed Web of Science ®Google Scholar
• Plotz FB. Surfactant therapy and extracorporeal life support. Crit Care. 2006 Feb;10(1):401.
   PubMed Web of Science ®Google Scholar
• Kamat PP, Popler J, Davis J, et al. Use of flexible bronchoscopy in pediatric patients receiving extracorporeal membrane oxygenation (ECMO) support. Pediatr Pulmonol. 2011 Nov;46(11):1108–1113.
   PubMed Web of Science ®Google Scholar
• Colby CE, Lally KP, Hintz SR, et al. Surfactant replacement therapy on ECMO does not improve outcome in neonates with congenital diaphragmatic hernia. J Pediatr Surg. 2004 Nov;39(11):1632–1637.
   PubMed Web of Science ®Google Scholar
• Dalton HJ, Reeder R, Garcia-Filion P, et al. Factors associated with bleeding and thrombosis in children receiving extracorporeal membrane oxygenation. Am J Respir Crit Care Med. 2017 Sep 15;196(6):762–771.
   PubMed Web of Science ®Google Scholar
• Peek GJ, Firmin RK. The inflammatory and coagulative response to prolonged extracorporeal membrane oxygenation. Asaio J. 1999 Jul-Aug;45(4):250–263.
   PubMed Web of Science ®Google Scholar
• Vallhonrat H, Swinford RD, Ingelfinger JR, et al. Rapid activation of the alternative pathway of complement by extracorporeal membrane oxygenation. Asaio J. 1999 Jan-Feb;45(1):113–114.
   PubMed Web of Science ®Google Scholar
• Arnold P, Jackson S, Wallis J, et al. Coagulation factor activity during neonatal extra-corporeal membrane oxygenation. Intensive Care Med. 2001 Aug;27(8):1395–1400.
   PubMed Web of Science ®Google Scholar
• McManus ML, Kevy SV, Bower LK, et al. Coagulation factor deficiencies during initiation of extracorporeal membrane oxygenation. J Pediatr. 1995 Jun;126(6):900–904.
   PubMed Web of Science ®Google Scholar
• Colby CE, Sheehan A, Benitz W, et al. Maintaining adequate anticoagulation on extracorporeal membrane oxygenation therapy: hemochron Junior Low Range versus Hemochron 400. J Extra Corpor Technol. 2003 Mar;35(1):35–38.
   PubMedGoogle Scholar
• Fleming GM, Gupta M, Cooley E, et al. Maintaining the standard: a quality assurance study for new equipment in the Michigan ECMO Program. Asaio J. 2007 Sep-Oct;53(5):556–560.
   PubMed Web of Science ®Google Scholar
• Perry DJ, Fitzmaurice DA, Kitchen S, et al. Point-of-care testing in haemostasis. Br J Haematol. 2010 Sep;150(5):501–514.
   PubMed Web of Science ®Google Scholar
• Extracorporeal Life Support Organization. ELSO Anticoagulation Guideline. Published 2014 [cited 2020 Oct 30]. Available from: https://www.elso.org/Portals/0/Files/elsoanticoagulationguideline8-2014-table-contents.pdf
   Google Scholar
• Ozment CP, Scott BL, Bembea MM, et al., Anticoagulation and transfusion management during neonatal and pediatric ECMO: a survey of medical directors in the United States. Pediatr Crit Care Med. 2021; (In press). Publish Ahead of Print. DOI:https://doi.org/10.1097/PCC.0000000000002696.
   Google Scholar
• Appel IM, Grimminck B, Geerts J, et al. Age dependency of coagulation parameters during childhood and puberty. J Thromb Haemost. 2012 Nov;10(11):2254–2263.
   PubMed Web of Science ®Google Scholar
• Agati S, Ciccarello G, Salvo D, et al. Use of a novel anticoagulation strategy during ECMO in a pediatric population: single-center experience. Asaio J. 2006 Sep-Oct;52(5):513–516.
   PubMed Web of Science ®Google Scholar
• Niebler RA, Christensen M, Berens R, et al. Antithrombin replacement during extracorporeal membrane oxygenation. Artif Organs. 2011 Nov;35(11):1024–1028.
   PubMed Web of Science ®Google Scholar
• Stansfield BK, Wise L, Ham PB 3rd, et al. Outcomes following routine antithrombin III replacement during neonatal extracorporeal membrane oxygenation. J Pediatr Surg. 2017 Apr;52(4):609–613.
   PubMed Web of Science ®Google Scholar
• Wong TE, Nguyen T, Shah SS, et al. Antithrombin concentrate use in pediatric extracorporeal membrane oxygenation: a multicenter cohort study. Pediatr Crit Care Med. 2016 Dec;17(12):1170–1178.
   PubMed Web of Science ®Google Scholar
• Chlebowski MM, Baltagi S, Carlson M, et al. Clinical controversies in anticoagulation monitoring and antithrombin supplementation for ECMO. Crit Care. 2020 Jan 20;24(1):19.
   PubMed Web of Science ®Google Scholar
• Warkentin TE. Bivalent direct thrombin inhibitors: hirudin and bivalirudin. Best Pract Res Clin Haematol. 2004 Mar;17(1):105–125.
   PubMed Web of Science ®Google Scholar
• Robson R, White H, Aylward P, et al. Bivalirudin pharmacokinetics and pharmacodynamics: effect of renal function, dose, and gender. Clin Pharmacol Ther. 2002 Jun;71(6):433–439.
   PubMed Web of Science ®Google Scholar
• Curvers J, van de Kerkhof D, Stroobants AK, et al. Measuring direct thrombin inhibitors with routine and dedicated coagulation assays: which assay is helpful? Am J Clin Pathol. 2012 Oct;138(4):551–558.
   PubMed Web of Science ®Google Scholar
• Linkins LA, Dans AL, Moores LK, et al. Treatment and prevention of heparin-induced thrombocytopenia: antithrombotic therapy and prevention of thrombosis, 9th ed: american college of chest physicians evidence-based clinical practice guidelines. Chest. 2012 Feb;141(2Suppl):e495S–e530S.
   PubMed Web of Science ®Google Scholar
• Nagle EL, Dager WE, Duby JJ, et al. Bivalirudin in pediatric patients maintained on extracorporeal life support. Pediatr Crit Care Med. 2013 May;14(4):e182–8.
   PubMed Web of Science ®Google Scholar
• Moffett BS, Teruya J. Trends in parenteral direct thrombin inhibitor use in pediatric patients: analysis of a large administrative database. Arch Pathol Lab Med. 2014 Sep;138(9):1229–1232.
   PubMed Web of Science ®Google Scholar
• Hamzah M, Jarden AM, Ezetendu C, et al. Evaluation of bivalirudin as an alternative to heparin for systemic anticoagulation in pediatric extracorporeal membrane oxygenation. Pediatr Crit Care Med. 2020 Sep;21(9):827–834.
   PubMed Web of Science ®Google Scholar
• Ryerson LM, Balutis KR, Granoski DA, et al. Prospective exploratory experience with bivalirudin anticoagulation in pediatric extracorporeal membrane oxygenation. Pediatr Crit Care Med. 2020 Nov;21(11):975–985.
   PubMed Web of Science ®Google Scholar
• Sanfilippo F, Asmussen S, Maybauer DM, et al. Bivalirudin for alternative anticoagulation in extracorporeal membrane oxygenation: a systematic review. J Intensive Care Med. 2017 Jun;32(5):312–319.
   PubMed Web of Science ®Google Scholar
• Prospective randomized pilot study comparing bivalirudin versus heparin in neonatal and pediatric extracorporeal membrane oxygenation. ClinicalTrials.gov identifier: NCT03318393. [cited 2020 Jun 19]. Available from: https://clinicaltrials.gov/ct2/show/NCT03318393
   Google Scholar
• Bembea MM, Annich G, Rycus P, et al. Variability in anticoagulation management of patients on extracorporeal membrane oxygenation: an international survey. Pediatr Crit Care Med. 2013 Feb;14(2):e77–84.
   PubMed Web of Science ®Google Scholar
• Bembea MM, Cheifetz IM, Fortenberry JD, et al. Recommendations on the Indications for RBC transfusion for the critically Ill child receiving support from extracorporeal membrane oxygenation, ventricular assist, and renal replacement therapy devices from the pediatric critical care transfusion and anemia expertise initiative. Pediatr Crit Care Med. 2018 Sep;19(9SSuppl 1):S157–s162.
   PubMed Web of Science ®Google Scholar
• Mazzeffi M, Greenwood J, Tanaka K, et al. Bleeding, transfusion, and mortality on extracorporeal life support: ECLS working group on thrombosis and hemostasis. Ann Thorac Surg. 2016 Feb;101(2):682–689.
   PubMed Web of Science ®Google Scholar
• Smith A, Hardison D, Bridges B, et al. Red blood cell transfusion volume and mortality among patients receiving extracorporeal membrane oxygenation. Perfusion. 2013 Jan;28(1):54–60.
   PubMed Web of Science ®Google Scholar
• Wildschut ED, Hanekamp MN, Vet NJ, et al. Feasibility of sedation and analgesia interruption following cannulation in neonates on extracorporeal membrane oxygenation. Intensive Care Med. 2010 Sep;36(9):1587–1591.
   PubMed Web of Science ®Google Scholar
• Schneider JB, Sweberg T, Asaro LA, et al. Sedation management in children supported on extracorporeal membrane oxygenation for acute respiratory failure. Crit Care Med. 2017 Oct;45(10):e1001–e1010.
   PubMed Web of Science ®Google Scholar
• Sutiman N, Koh JC, Watt K, et al. Pharmacokinetics alterations in critically Ill pediatric patients on extracorporeal membrane oxygenation: a systematic review. Front Pediatr. 2020;8:260.
   PubMed Web of Science ®Google Scholar
• Harthan AA, Buckley KW, Heger ML, et al. Medication adsorption into contemporary extracorporeal membrane oxygenator circuits. J Pediatr Pharmacol Ther. 2014 Oct-Dec;19(4):288–295.
   PubMedGoogle Scholar
• Shekar K, Roberts JA, McDonald CI, et al. Sequestration of drugs in the circuit may lead to therapeutic failure during extracorporeal membrane oxygenation. Crit Care. 2012 Oct 15;16(5):R194.
   PubMed Web of Science ®Google Scholar
• Shekar K, Roberts JA, McDonald CI, et al. Protein-bound drugs are prone to sequestration in the extracorporeal membrane oxygenation circuit: results from an ex vivo study. Crit Care. 2015 Apr 14;19(1):164.
   PubMed Web of Science ®Google Scholar
• Mehta NM, Halwick DR, Dodson BL, et al. Potential drug sequestration during extracorporeal membrane oxygenation: results from an ex vivo experiment. Intensive Care Med. 2007 Jun;33(6):1018–1024.
   PubMed Web of Science ®Google Scholar
• Preston TJ, Hodge AB, Riley JB, et al. In vitro drug adsorption and plasma free hemoglobin levels associated with hollow fiber oxygenators in the extracorporeal life support (ECLS) circuit. J Extra Corpor Technol. 2007 Dec;39(4):234–237.
   PubMedGoogle Scholar
• Preston TJ, Ratliff TM, Gomez D, et al. Modified surface coatings and their effect on drug adsorption within the extracorporeal life support circuit. J Extra Corpor Technol. 2010 Sep;42(3):199–202.
   PubMedGoogle Scholar
• Nasr VG, Meserve J, Pereira LM, et al. Sedative and analgesic drug sequestration after a single bolus injection in an ex vivo extracorporeal membrane oxygenation infant circuit. Asaio J. 2019 Feb;65(2):187–191.
   PubMed Web of Science ®Google Scholar
• Raffaeli G, Allegaert K, Koch B, et al. In vitro adsorption of analgosedative drugs in new extracorporeal membrane oxygenation circuits. Pediatr Crit Care Med. 2018 May;19(5):e251–e258.
   PubMed Web of Science ®Google Scholar
• Arnold JH, Truog RD, Orav EJ, et al. Tolerance and dependence in neonates sedated with fentanyl during extracorporeal membrane oxygenation. Anesthesiology. 1990 Dec;73(6):1136–1140.
   PubMed Web of Science ®Google Scholar
• Dagan O, Klein J, Bohn D, et al. Effects of extracorporeal membrane oxygenation on morphine pharmacokinetics in infants. Crit Care Med. 1994 Jul;22(7):1099–1101.
   PubMed Web of Science ®Google Scholar
• Geiduschek JM, Lynn AM, Bratton SL, et al. Morphine pharmacokinetics during continuous infusion of morphine sulfate for infants receiving extracorporeal membrane oxygenation. Crit Care Med. 1997 Feb;25(2):360–364.
   PubMed Web of Science ®Google Scholar
• Southgate WM, DiPiro JT, Robertson AF. Pharmacokinetics of gentamicin in neonates on extracorporeal membrane oxygenation. Antimicrob Agents Chemother. 1989 Jun;33(6):817–819.
   PubMed Web of Science ®Google Scholar
• Cohen P, Collart L, Prober CG, et al. Gentamicin pharmacokinetics in neonates undergoing extracorporal membrane oxygenation. Pediatr Infect Dis J. 1990 Aug;9(8):562–566.
   PubMed Web of Science ®Google Scholar
• Cies JJ, Shankar V, Schlichting C, et al. Population pharmacokinetics of piperacillin/tazobactam in critically ill young children. Pediatr Infect Dis J. 2014 Feb;33(2):168–173.
   PubMed Web of Science ®Google Scholar
• Autmizguine J, Hornik CP, Benjamin DK Jr., et al. Pharmacokinetics and safety of micafungin in infants supported with extracorporeal membrane oxygenation. Pediatr Infect Dis J. 2016 Nov;35(11):1204–1210.
   PubMed Web of Science ®Google Scholar
• Ahsman MJ, Wildschut ED, Tibboel D, et al. Pharmacokinetics of cefotaxime and desacetylcefotaxime in infants during extracorporeal membrane oxygenation. Antimicrob Agents Chemother. 2010 May;54(5):1734–1741.
   PubMed Web of Science ®Google Scholar
• Watt KM, Gonzalez D, Benjamin DK Jr., et al. Fluconazole population pharmacokinetics and dosing for prevention and treatment of invasive Candidiasis in children supported with extracorporeal membrane oxygenation. Antimicrob Agents Chemother. 2015 Jul;59(7):3935–3943.
   PubMed Web of Science ®Google Scholar
• Watt KM, Benjamin DK Jr., Cheifetz IM, et al. Pharmacokinetics and safety of fluconazole in young infants supported with extracorporeal membrane oxygenation. Pediatr Infect Dis J. 2012 Oct;31(10):1042–1047.
   PubMed Web of Science ®Google Scholar
• Mulla H, McCormack P, Lawson G, et al. Pharmacokinetics of midazolam in neonates undergoing extracorporeal membrane oxygenation. Anesthesiology. 2003 Aug;99(2):275–282.
   PubMed Web of Science ®Google Scholar
• Kleiber N, Mathôt RAA, Ahsman MJ, et al. Population pharmacokinetics of intravenous clonidine for sedation during paediatric extracorporeal membrane oxygenation and continuous venovenous hemofiltration. Br J Clin Pharmacol. 2017 Jun;83(6):1227–1239.
   PubMed Web of Science ®Google Scholar
• Ahsman MJ, Witjes BC, Wildschut ED, et al. Sildenafil exposure in neonates with pulmonary hypertension after administration via a nasogastric tube. Arch Dis Child Fetal Neonatal Ed. 2010 Mar;95(2):F109–14.
   PubMed Web of Science ®Google Scholar
• Cies JJ, Moore WS 2nd, Miller K, et al. Therapeutic drug monitoring of continuous-infusion acylovir for disseminated herpes simplex virus infection in a neonate receiving concurrent extracorporeal life support and continuous renal replacement therapy. Pharmacotherapy. 2015 Feb;35(2):229–233.
   PubMed Web of Science ®Google Scholar
• Aebi C, Headrick CL, McCracken GH, et al. Intravenous ribavirin therapy in a neonate with disseminated adenovirus infection undergoing extracorporeal membrane oxygenation: pharmacokinetics and clearance by hemofiltration. J Pediatr. 1997 Apr;130(4):612–615.
   PubMed Web of Science ®Google Scholar
• Watt KM, Hornik CP, Balevic SJ, et al. Pharmacokinetics of ticarcillin-clavulanate in premature infants. Br J Clin Pharmacol. 2019 May;85(5):1021–1027.
   PubMed Web of Science ®Google Scholar
• Lindsay CA, Bawdon R, Quigley R. Clearance of ticarcillin-clavulanic acid by continuous venovenous hemofiltration in three critically ill children, two with and one without concomitant extracorporeal membrane oxygenation. Pharmacotherapy. 1996 May-Jun;16(3):458–462.
   PubMed Web of Science ®Google Scholar
• Wells TG, Heulitt MJ, Taylor BJ, et al. Pharmacokinetics and pharmacodynamics of ranitidine in neonates treated with extracorporeal membrane oxygenation. J Clin Pharmacol. 1998 May;38(5):402–407.
   PubMed Web of Science ®Google Scholar
• Wells TG, Fasules JW, Taylor BJ, et al. Pharmacokinetics and pharmacodynamics of bumetanide in neonates treated with extracorporeal membrane oxygenation. J Pediatr. 1992 Dec;121(6):974–980.
   PubMed Web of Science ®Google Scholar
• Ahsman MJ, Hanekamp M, Wildschut ED, et al. Population pharmacokinetics of midazolam and its metabolites during venoarterial extracorporeal membrane oxygenation in neonates. Clin Pharmacokinet. 2010 Jun;49(6):407–419.
   PubMed Web of Science ®Google Scholar
• Olguín HJ, Martínez HO, Pérez CF, et al. Pharmacokinetics of sildenafil in children with pulmonary arterial hypertension. World J Pediatr. 2017 Dec;13(6):588–592.
   PubMed Web of Science ®Google Scholar
• Koch BC, Wildschut ED, Goede AL, et al. Insufficient serum caspofungin levels in a paediatric patient on ECMO. Med Mycol Case Rep. 2012 Dec 26;2:23–24.
   PubMedGoogle Scholar
• Peters JW, Anderson BJ, Simons SH, et al. Morphine metabolite pharmacokinetics during venoarterial extra corporeal membrane oxygenation in neonates. Clin Pharmacokinet. 2006;45(7):705–714.
   PubMed Web of Science ®Google Scholar
• Meehan JJ, Haney BM, Snyder CL, et al. Outcome after recannulation and a second course of extracorporeal membrane oxygenation. J Pediatr Surg. 2002 Jun;37(6):845–850.
   PubMed Web of Science ®Google Scholar
• Brogan TV, Zabrocki L, Thiagarajan RR, et al. Prolonged extracorporeal membrane oxygenation for children with respiratory failure. Pediatr Crit Care Med. 2012 Jul;13(4):e249–54.
   PubMed Web of Science ®Google Scholar
• Prodhan P, Stroud M, El-Hassan N, et al. Prolonged extracorporeal membrane oxygenator support among neonates with acute respiratory failure: a review of the extracorporeal life support organization registry. Asaio J. 2014 Jan-Feb;60(1):63–69.
   PubMed Web of Science ®Google Scholar
• Rehder KJ, Turner DA, Bonadonna D, et al. State of the art: strategies for extracorporeal membrane oxygenation in respiratory failure. Expert Rev Respir Med. 2012 Nov;6(5):513–521.
   PubMed Web of Science ®Google Scholar
• Nelson-mcmillan K, Vricella LA, Stewart FD, et al. Recovery from total acute lung failure after 20 months of extracorporeal life support. ASAIO Journal. 2012 Jan;6(5):e11–e14.
   Google Scholar
• Rosenberg AA, Haft JW, Bartlett R, et al. Prolonged duration ECMO for ARDS: futility, native lung recovery, or transplantation? Asaio J. 2013 Nov-Dec;59(6):642–650.
   PubMed Web of Science ®Google Scholar
• Mausert et al. RT ECMO Specialist Driven Sweep Trials Reduce Time to Sweep Trial Initiation and ECMO Duration in Patients Requiring V-V ECMO for ARDS. ELSO Meeting Abstracts; 2019.
   Google Scholar
• Pandya NR, Daley M, Mattke A, et al. A comparison of pump-controlled retrograde trial off to arterio-venous bridging for weaning from venoarterial extracorporeal membrane oxygenation. Eur J Cardiothorac Surg. 2019 Jan 29;56(2):277–284.
   Web of Science ®Google Scholar
• Freeman CL, Bennett TD, Casper TC, et al. Pediatric and neonatal extracorporeal membrane oxygenation: does center volume impact mortality?*. Crit Care Med. 2014 Mar;42(3):512–519.
   PubMed Web of Science ®Google Scholar
• Gonzalez DO, Sebastião YV, Cooper JN, et al. Pediatric extracorporeal membrane oxygenation mortality is related to extracorporeal membrane oxygenation volume in US hospitals. J Surg Res. 2019 Apr;236:159–165.
   PubMed Web of Science ®Google Scholar